CORRECTION article

Front. Pharmacol., 28 November 2017

Sec. Experimental Pharmacology and Drug Discovery

Volume 8 - 2017 | https://doi.org/10.3389/fphar.2017.00890

Corrigendum: Novel Peripherally Restricted Cannabinoid 1 Receptor Selective Antagonist TXX-522 with Prominent Weight-Loss Efficacy in Diet Induced Obese Mice

  • WC

    Wei Chen 1,2

  • FS

    Fengchun Shui 1,2

  • CL

    Cheng Liu 3

  • XZ

    Xinbo Zhou 1,2

  • WL

    Wei Li 1,2

  • ZZ

    Zhibing Zheng 1,2

  • WF

    Wei Fu 3

  • LW

    Lili Wang 1,2*

  • 1. Beijing Institute of Pharmacology and Toxicology, Beijing, China

  • 2. State Key Laboratory of Toxicology and Medical Countermeasures, Beijing, China

  • 3. Department of Medicinal Chemistry, School of Pharmacy, Fudan University, Shanghai, China

There is an error in the Funding statement. The correct number for the Major Program of the Ministry of Science and Technology of China is 2012ZX09301-001, 2012ZX09301-003.

In the original article, we neglected to include the funder the National Natural Science Foundation of China, 81430090 to LW.

The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way.

Statements

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Summary

Keywords

CB1R antagonist, obesity, periphery, blood–brain-barrier

Citation

Chen W, Shui F, Liu C, Zhou X, Li W, Zheng Z, Fu W and Wang L (2017) Corrigendum: Novel Peripherally Restricted Cannabinoid 1 Receptor Selective Antagonist TXX-522 with Prominent Weight-Loss Efficacy in Diet Induced Obese Mice. Front. Pharmacol. 8:890. doi: 10.3389/fphar.2017.00890

Received

08 November 2017

Accepted

20 November 2017

Published

28 November 2017

Volume

8 - 2017

Edited and reviewed by

Ming Wang, Phanes Therapeutics, United States

Updates

Copyright

*Correspondence: Lili Wang

This article was submitted to Experimental Pharmacology and Drug Discovery, a section of the journal Frontiers in Pharmacology

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics